DormaTarg provides a number of preclinical services to pharmaceutical companies and academic researchers. We have skilled team of pharmacologists, toxicologists, biochemists, cancer biologists and clinicians to help design and oversee these studies. In addition to services traditionally provided by other contract research organizations (CROs), DormaTarg also offers a host drug discovery services tailored to a project at any stage in its evolution.

Services

DormaTarg Services

Services

News

  • Nov. 1, 2011 - DormaTarg awarded SBIR Phase II Grant for $2MM

  • Dec. 3, 2010 - DormaTarg awarded OCAST R&D Intern Partnerships Grant for $47,000

  • Dec. 2, 2010 - Dr. Ihnat awarded OARS Grant for $91,570

  • Nov. 1, 2010 - DormaTarg awarded Qualifying Therapeutic Discovery Project for $173,044